rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2005-1-24
|
pubmed:abstractText |
We have developed a therapeutic for the treatment of anthrax using an affinity-enhanced monoclonal antibody (ETI-204) to protective antigen (PA), which is the central cell-binding component of the anthrax exotoxins. ETI-204 administered preexposure by a single intravenous injection of a dose of between 2.5 and 10 mg per animal significantly protected rabbits from a lethal aerosolized anthrax spore challenge ( approximately 60 to 450 times the 50% lethal dose of Bacillus anthracis Ames). Against a similar challenge, ETI-204 administered intramuscularly at a 20-mg dose per animal completely protected rabbits from death (100% survival). In the postexposure setting, intravenous administration of ETI-204 provided protection 24 h (8 of 10) and 36 h (5 of 10) after spore challenge. Administration at 48 h postchallenge, when 3 of 10 animals had already succumbed to anthrax infection, resulted in the survival of 3 of 7 animals (43%) for the duration of the study (28 days). Importantly, surviving ETI-204-treated animals were free of bacteremia by day 10 and remained so until the end of the studies. Only 11 of 51 ETI-204-treated rabbits had positive lung cultures at the end of the studies. Also, rabbits that were protected from inhalational anthrax by administration of ETI-204 developed significant titers of PA-specific antibodies. Presently, the sole therapeutic regimen available to treat infection by inhalation of B. anthracis spores is a 60-day course of antibiotics that is effective only if administered prior to or shortly after exposure. Based upon results reported here, ETI-204 is an effective therapy for prevention and treatment of inhalational anthrax.
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-10085027,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-10328075,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-10477781,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-11292703,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-11312020,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-11390699,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-11483266,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-11535328,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-11544370,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-11700562,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-11796581,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-11997437,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-12042864,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-12396909,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-12435060,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-12468536,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-12700348,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-1438214,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-14670324,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-15044490,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-1909998,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-2111283,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-2470825,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-3148815,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-3384478,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-3711080,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-3917427,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-6285339,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-7086666,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-7783638,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-8051159,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-8380282,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-8486963,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-9039918,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-9393812,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-9563949,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-9632621,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-9682372,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-9822127
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0019-9567
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
73
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
795-802
|
pubmed:dateRevised |
2010-9-20
|
pubmed:meshHeading |
pubmed-meshheading:15664918-Animals,
pubmed-meshheading:15664918-Anthrax,
pubmed-meshheading:15664918-Antibodies, Monoclonal,
pubmed-meshheading:15664918-Antigens, Bacterial,
pubmed-meshheading:15664918-Bacillus anthracis,
pubmed-meshheading:15664918-Bacterial Toxins,
pubmed-meshheading:15664918-Blood,
pubmed-meshheading:15664918-Injections, Intramuscular,
pubmed-meshheading:15664918-Rabbits,
pubmed-meshheading:15664918-Spores, Bacterial,
pubmed-meshheading:15664918-Time Factors
|
pubmed:year |
2005
|
pubmed:articleTitle |
A high-affinity monoclonal antibody to anthrax protective antigen passively protects rabbits before and after aerosolized Bacillus anthracis spore challenge.
|
pubmed:affiliation |
Elusys Therapeutics Inc., P.O. Box 102, 25 Riverside Drive, Pine Brook, NJ 07058, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't
|